TY - JOUR
T1 - The influence of chronic morphine treatment on the negative feedback regulation of gonadotropin secretion by gonadal steroids
AU - Gabriel, Steven M.
AU - Berglund, Lee Ann
AU - Kalra, Satya P.
AU - Kalra, Pushpa S.
AU - Simpkins, James W.
PY - 1986/12
Y1 - 1986/12
N2 - The influence of continuous stimulation of opiate receptors with morphine (M) on the negative feedback effects of testosterone (T), 5a-dihydrotestosterone (DHT), and 17β-estradiol (E2) on LH and FSH secretion was studied in rats that had been castrated 2 weeks previously. In the absence of gonadal steroids, 4 days of continuous M exposure did not alter LH or FSH levels. Similarly, Silastic capsules containing crystalline T 5 mm) or E2 [5 mm long (75 μg E2/ml) to 7.5 mm long (300 ng E2/ml)] alone had little effect on LH or FSH release. However, in M-exposed rats, T reduced serum LH by greater than 90%, and E2 reduced LH by more than 75%. Among the doses of DHT evaluated, only the highest dose (7.5-mm Silastic capsules packed with crystalline DHT) reduced LH secretion, and M exposure only slightly enhanced this suppression. M or gonadal steroids alone produced little change in FSH levels in castrated rats. However, the combination of M plus E2 or DHT further reduced FSH levels. Evaluation of pituitary responses to LHRH revealed that when administered alone, T did not alter, DHT reduced, and E2 enhanced the LH response to the decapeptide. Neither M treatment alone nor M plus T or DHT altered the pituitary LH response to LHRH. On the other hand, M appeared to enhance the stimulatory effects of E2 on pituitary responsiveness to LHRH. These findings suggest that the interaction of M and gonadal steroids at the level of the pituitary could not explain the observed marked suppression of gonadotropin secretion by suboptimal T or E2 during opiate receptor stimulation with M. Collectively, these observations are in accord with the view that endogenous opioid peptides may play a role in modulating the sensitivity of the hypothalamus to the negative feedback effects of gonadal steroids.
AB - The influence of continuous stimulation of opiate receptors with morphine (M) on the negative feedback effects of testosterone (T), 5a-dihydrotestosterone (DHT), and 17β-estradiol (E2) on LH and FSH secretion was studied in rats that had been castrated 2 weeks previously. In the absence of gonadal steroids, 4 days of continuous M exposure did not alter LH or FSH levels. Similarly, Silastic capsules containing crystalline T 5 mm) or E2 [5 mm long (75 μg E2/ml) to 7.5 mm long (300 ng E2/ml)] alone had little effect on LH or FSH release. However, in M-exposed rats, T reduced serum LH by greater than 90%, and E2 reduced LH by more than 75%. Among the doses of DHT evaluated, only the highest dose (7.5-mm Silastic capsules packed with crystalline DHT) reduced LH secretion, and M exposure only slightly enhanced this suppression. M or gonadal steroids alone produced little change in FSH levels in castrated rats. However, the combination of M plus E2 or DHT further reduced FSH levels. Evaluation of pituitary responses to LHRH revealed that when administered alone, T did not alter, DHT reduced, and E2 enhanced the LH response to the decapeptide. Neither M treatment alone nor M plus T or DHT altered the pituitary LH response to LHRH. On the other hand, M appeared to enhance the stimulatory effects of E2 on pituitary responsiveness to LHRH. These findings suggest that the interaction of M and gonadal steroids at the level of the pituitary could not explain the observed marked suppression of gonadotropin secretion by suboptimal T or E2 during opiate receptor stimulation with M. Collectively, these observations are in accord with the view that endogenous opioid peptides may play a role in modulating the sensitivity of the hypothalamus to the negative feedback effects of gonadal steroids.
UR - https://www.scopus.com/pages/publications/0022971135
U2 - 10.1210/endo-119-6-2762
DO - 10.1210/endo-119-6-2762
M3 - Article
C2 - 3096696
AN - SCOPUS:0022971135
SN - 0013-7227
VL - 119
SP - 2762
EP - 2767
JO - Endocrinology
JF - Endocrinology
IS - 6
ER -